It is also reportedly effective when combined with IFN therapy for hepatitis C with thrombocytopenia (27); however, the invasive nature of the procedure means that its indications are limited to those in which it is expected to deliver an adequate response. The gene discussed is IFNA1; the disease is hepatitis C virus infection.